title: Prediction of HIV Drug Resistance by Combining Sequence and Structural Properties.
abstract: Drug resistance is a major obstacle faced by therapist in treating HIV infected patients. The reason behind these phenomena is either protein mutation or the changes in gene expression level that induces resistance to drug treatments. These mutations affect the drug binding activity, hence resulting in failure of treatment. Therefore, it is necessary to conduct resistance testing in order to carry out HIV effective therapy. This study combines both sequence and structural features for predicting HIV resistance by applying SVM and Random Forests classifiers. The model was tested on the mutants of HIV-1 protease and reverse transcriptase. Taken together the features we have used in our method, total contact energies among multiple mutations have a strong impact in predicting resistance as they are crucial in understanding the interactions of HIV mutants. The combination of sequence-structure features offers high accuracy with support vector machines as compared to Random Forests classifier. Both single and acquisition of multiple mutations are important in predicting HIV resistance to certain drug treatments. We have discovered the practicality of these features; hence, these can be used in the future to predict resistance for other complex diseases.
authors.forename: Zoya
authors.initials: Z
authors.lastname: Khalid
authors.forename: Osman Ugur
authors.initials: OU
authors.lastname: Sezerman
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology; D019295:Computational Biology / Q000379:methods*; D057225:Data Mining / Q000379:methods*; D024882:Drug Resistance, Viral / Q000235:genetics / Q000502:physiology; D015658:HIV Infections / Q000821:virology*; D016333:HIV Protease / Q000737:chemistry / Q000235:genetics; D054303:HIV Reverse Transcriptase / Q000737:chemistry / Q000235:genetics; D015497:HIV-1 / Q000737:chemistry / Q000187:drug effects / Q000235:genetics; D006801:Humans; D009154:Mutation / Q000235:genetics / Q000502:physiology; D060388:Support Vector Machine
chemical_list: D000998:Antiviral Agents; D054303:HIV Reverse Transcriptase; D016333:HIV Protease; C514803:p16 protease, Human immunodeficiency virus 1